CoMentis Garners $4,500,000 Series E Financing

  • Feed Type
  • Date
    3/21/2016
  • Company Name
    CoMentis
  • Mailing Address
    280 Utah Avenue South San Francisco, CA 94080 USA
  • Company Description
    CoMentis is engaged in the discovery and development of small-molecule drugs to treat neurovascular disease such as Alzheimer’s disease, AMD and cognitive disorders.
  • Website
    http://www.comentis.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $4,500,000
  • Transaction Round
    Series E
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 2 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy